BRIM Biotechnology, Inc. (TPE:6885)
Taiwan
· Delayed Price · Currency is TWD 21.85
-0.60 (-2.67%)
At close: May 13, 2025
BRIM Biotechnology Market Cap
BRIM Biotechnology has a market cap or net worth of 2.96 billion as of May 20, 2025. Its market cap has decreased by -14.80% in one year.
Market Cap
2.96B
Enterprise Value
1.18B
Revenue
433.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
21.85
Market Cap Chart
Since June 23, 2022, BRIM Biotechnology's market cap has increased from 1.77B to 2.96B, an increase of 67.82%. That is a compound annual growth rate of 19.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2025 | 2.96B | -27.14% |
| Dec 31, 2024 | 4.07B | 17.34% |
| Dec 29, 2023 | 3.47B | -2.55% |
| Dec 30, 2022 | 3.56B | 101.45% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 166.35B |
| Caliway Biopharmaceuticals | 128.17B |
| Bora Pharmaceuticals Co., LTD. | 73.69B |
| Lotus Pharmaceutical | 58.99B |
| Polaris Group | 33.43B |
| Oneness Biotech | 29.80B |
| Pegavision | 27.38B |
| Center Laboratories | 27.38B |